AGL 39.50 Decreased By ▼ -0.50 (-1.25%)
AIRLINK 131.70 Increased By ▲ 2.64 (2.05%)
BOP 6.81 Increased By ▲ 0.06 (0.89%)
CNERGY 4.73 Increased By ▲ 0.24 (5.35%)
DCL 8.49 Decreased By ▼ -0.06 (-0.7%)
DFML 41.45 Increased By ▲ 0.63 (1.54%)
DGKC 82.15 Increased By ▲ 1.19 (1.47%)
FCCL 33.25 Increased By ▲ 0.48 (1.46%)
FFBL 72.58 Decreased By ▼ -1.85 (-2.49%)
FFL 12.40 Increased By ▲ 0.66 (5.62%)
HUBC 110.74 Increased By ▲ 1.16 (1.06%)
HUMNL 14.40 Increased By ▲ 0.65 (4.73%)
KEL 5.18 Decreased By ▼ -0.13 (-2.45%)
KOSM 7.65 Decreased By ▼ -0.07 (-0.91%)
MLCF 38.85 Increased By ▲ 0.25 (0.65%)
NBP 63.78 Increased By ▲ 0.27 (0.43%)
OGDC 192.51 Decreased By ▼ -2.18 (-1.12%)
PAEL 25.60 Decreased By ▼ -0.11 (-0.43%)
PIBTL 7.37 Decreased By ▼ -0.02 (-0.27%)
PPL 153.85 Decreased By ▼ -1.60 (-1.03%)
PRL 25.85 Increased By ▲ 0.06 (0.23%)
PTC 17.75 Increased By ▲ 0.25 (1.43%)
SEARL 82.10 Increased By ▲ 3.45 (4.39%)
TELE 7.80 Decreased By ▼ -0.06 (-0.76%)
TOMCL 33.49 Decreased By ▼ -0.24 (-0.71%)
TPLP 8.50 Increased By ▲ 0.10 (1.19%)
TREET 16.60 Increased By ▲ 0.33 (2.03%)
TRG 57.49 Decreased By ▼ -0.73 (-1.25%)
UNITY 27.61 Increased By ▲ 0.12 (0.44%)
WTL 1.37 Decreased By ▼ -0.02 (-1.44%)
BR100 10,495 Increased By 50 (0.48%)
BR30 31,202 Increased By 12.3 (0.04%)
KSE100 98,080 Increased By 281.6 (0.29%)
KSE30 30,559 Increased By 78 (0.26%)

Scientists said Wednesday they had grown rudimentary human kidney tissue from stem cells, a key step towards the Holy Grail of fully-functional, lab-made transplant organs. The tissue is not a viable organ, but may be useful for other purposes such as replacing animals in drug toxicity tests, the team said. The researchers from Australia and the Netherlands grew their "kidney-like structure" from induced pluripotent stem (iPS) cells - adult cells reprogrammed into a neutral state from which they can be coaxed to develop into other cell types.
Given the critical shortage of donor organs to replace those damaged by accident or disease, it has long been a goal of science to create human organs from stem cells. But it is a complicated task. Scientists need to prompt stem cells to become kidney, liver or lung cells, which must then recreate the complex anatomy of a real organ in order to function in a human recipient. The first part of this chain has proved most challenging, especially in organs composed of a multitude of different cell types. The kidney, for example, has more than 20.
In the new study, published in the journal Nature, the team managed to transform iPS cells into two different adult cell types. The resulting organoids sported different tissue types and were "similar" to the kidney of a human embryo, the researchers reported. The work represented "an important step towards building stem-cell-derived kidneys," University of Edinburgh anatomy expert Jamie Davies wrote in a comment, also published by Nature.
But he stressed the product was "not a kidney, but an organoid". "There is a long way to go until clinically useful transplantable kidneys can be engineered," Davies said. But the organoids may fulfil a completely different medical need - testing the safety for humans of new drugs.

Copyright Agence France-Presse, 2015

Comments

Comments are closed.